Delivery Order SPE2DB24D1021-SPE2DB25FEXVL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,282.14 to AmerisourceBergen Drug Corp for the supply of Prezcobix 800 mg-150 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- This is a $57,504.07 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of PREZCOBIX 800 MG-150 MG TABLET 30S. The contract has an ultimate completion date of March 6, 2025 and was awarded on March 5, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, including the...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,889.29 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S. This contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,369.44, is for the delivery of 4567943668 PREZCOBIX 800 MG-150 MG TABLET 30S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of April 17, 2025. It is not designated as a set-aside contract, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,617.72, is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $19,016.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 25, 2025. It is not designated as a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $127,427.56 contract is for the provision of PREZCOBIX 800 MG-150 MG tablets to support DLA Troop Support Medical programs. As a prime contractor, Amerisourcebergen Drug Corp has previously supplied pharmaceuticals, medical supplies, and distribution services to the Department of Defense. This...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $17,044.17 firm fixed-price contract is for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product, with a period of performance through October 2, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $17,599.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the pharmaceutical product Prezcobix 800 mg-150 mg tablets. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB22D3016) valued at $11,461.54 to provide 4564249212 PREZCOBIX 800 MG-150 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (SPE2DB24FASJ8) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00, which serves as the primary contract vehicle for...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXVLDelivery Order
The Defense Logistics Agency awarded a $9,280.01 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Prezcobix 800 mg-150 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by June 18, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 potential value and extends through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, with extensive experience supplying brand-name and generic medications to military and veteran healthcare systems. The SPE2DX indefinite delivery vehicle enables the company to provide comprehensive pharmaceutical support globally, encompassing specialty medications, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Prezcobix—an antiretroviral medication used in HIV treatment—aligns with the company's established role as a critical supplier of specialized pharmaceutical products within the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 6/17/25 |